Shoshiro Okada
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shoshiro Okada has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Naoko Yamaguchi
Department of Pharmacology, School of Medicine, Aichi Medical University
3 shared publications- Fumio Kondo
Department of Toxicology, Aichi Prefectural Institute of Public Health, 7-6 Nagare, Tsuji-machi, Kita-ku, Nagoya 462-8576, Japan
2 shared publications - Guo-Gang Feng
Department of Anesthesiology, Aichi Medical University School of Medicine, 1-1 Yazakokarimata, Nagakute 480-1195, Aichi, Japan
2 shared publications - Koji Tsunekawa
Department of Pharmacology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan
2 shared publications - Lei Huang
Aichi Medical University School of Medicine
2 shared publications Masahiko Tachi
Aichi Prefectural Institute of Public Health, Japan
2 shared publications
Latest Publications
- Open Access
- 1 January 2023
- Published by Japanese Pharmacological Society in Folia Pharmacologica Japonica
- Vol. 158 (2) , 134-137
Practices and challenges of joint education at two medical schools utilizing online pharmacology role-playing
学生同士が医療者と患者に扮して病気や薬物治療の説明を行う“学生主体型ロールプレイによる実践的薬物治療教育”「薬理学ロールプレイ」は,薬理学アクティブ・ラーニングの一つである.しかし,これまでは一施設内でのみ実施しており,多職種も含めたより規模を大きくした異なる多施設間においては実施されてこなかった.ところが,2020年度のCOVID-19感染拡大は,旧来の対面講義を中心とした医学部教育のやり方を大きく変える転機となった.なかでもZoom等を活用した遠隔リアルタイム授業は,多施設間で,300名程度の学生であれば同時に一ヵ所に集める必要なく実施できるメリットがある.コロナ禍を奇貨として,異なる多施設間による薬理学ロールプレイの合同教育を実施できるインフラが整ったことになる.我々は全国に先駆けて藤田医科大学と愛知医科大学の2大学合同で薬理学ロールプレイを実施したので,その内容を紹介する.
- 1 January 2023
- Published by Japanese Pharmacological Society in Folia Pharmacologica Japonica
- Vol. 158 (2) , 134-137
Open AccessPractices and challenges of joint education at two medical schools utilizing online pharmacology role-playing
学生同士が医療者と患者に扮して病気や薬物治療の説明を行う“学生主体型ロールプレイによる実践的薬物治療教育”「薬理学ロールプレイ」は,薬理学アクティブ・ラーニングの一つである.しかし,これまでは一施設内でのみ実施しており,多職種も含めたより規模を大きくした異なる多施設間においては実施されてこなかった.ところが,2020年度のCOVID-19感染拡大は,旧来の対面講義を中心とした医学部教育のやり方を大きく変える転機となった.なかでもZoom等を活用した遠隔リアルタイム授業は,多施設間で,300名程度の学生であれば同時に一ヵ所に集める必要なく実施できるメリットがある.コロナ禍を奇貨として,異なる多施設間による薬理学ロールプレイの合同教育を実施できるインフラが整ったことになる.我々は全国に先駆けて藤田医科大学と愛知医科大学の2大学合同で薬理学ロールプレイを実施したので,その内容を紹介する.
- Open Access
- 22 February 2022
- Published by Elsevier in Autonomic Neuroscience
- Vol. 239, 102957
Glucose infusion suppresses acute restraint stress-induced peripheral and central sympathetic responses in rats
- 22 February 2022
- Published by Elsevier in Autonomic Neuroscience
- Vol. 239, 102957
Open AccessGlucose infusion suppresses acute restraint stress-induced peripheral and central sympathetic responses in rats
- 1 May 2020
- Published by Elsevier in European Journal of Pharmacology
- Vol. 875, 173034
Thromboxane A2 in the paraventricular hypothalamic nucleus mediates glucoprivation-induced adrenomedullary outflow
- 1 May 2020
- Published by Elsevier in European Journal of Pharmacology
- Vol. 875, 173034
Thromboxane A2 in the paraventricular hypothalamic nucleus mediates glucoprivation-induced adrenomedullary outflow
- Open Access
- 1 March 2017
- Published by Elsevier in Autonomic Neuroscience
- Vol. 203, 74-80
Possible role of adrenoceptors in the hypothalamic paraventricular nucleus in corticotropin-releasing factor-induced sympatho-adrenomedullary outflow in rats
- 1 March 2017
- Published by Elsevier in Autonomic Neuroscience
- Vol. 203, 74-80
Open AccessPossible role of adrenoceptors in the hypothalamic paraventricular nucleus in corticotropin-releasing factor-induced sympatho-adrenomedullary outflow in rats
- 1 May 2015
- Published by Elsevier in Autonomic Neuroscience
- Vol. 189, 1-7
Centrally administered isoproterenol induces sympathetic outflow via brain prostaglandin E2-mediated mechanisms in rats
- 1 May 2015
- Published by Elsevier in Autonomic Neuroscience
- Vol. 189, 1-7
Centrally administered isoproterenol induces sympathetic outflow via brain prostaglandin E2-mediated mechanisms in rats
- Open Access
- 7 January 2013
- Published by Springer Nature in BMC Neuroscience
- Vol. 14 (1) , 4
Enhanced expression of WD repeat-containing protein 35 (WDR35) stimulated by domoic acid in rat hippocampus: involvement of reactive oxygen species generation and p38 mitogen-activated protein kinase activation
Domoic acid (DA) is an excitatory amino acid analogue of kainic acid (KA) that acts via activation of glutamate receptors to elicit a rapid and potent excitotoxic response, resulting in neuronal cell death. Recently, DA was shown to elicit reactive oxygen species (ROS) production and induce apoptosis accompanied by activation of p38 mitogen-activated protein kinase (MAPK) in vitro. We have reported that WDR35, a WD-repeat protein, may mediate apoptosis in several animal models. In the present study, we administered DA to rats intraperitoneally, then used liquid chromatography/ion trap tandem mass spectrometry (LC-MS/MS) to identify and quantify DA in the brains of the rats and performed histological examinations of the hippocampus. We further investigated the potential involvement of glutamate receptors, ROS, p38 MAPK, and WDR35 in DA-induced toxicity in vivo.
- 7 January 2013
- Published by Springer Nature in BMC Neuroscience
- Vol. 14 (1) , 4
Open AccessEnhanced expression of WD repeat-containing protein 35 (WDR35) stimulated by domoic acid in rat hippocampus: involvement of reactive oxygen species generation and p38 mitogen-activated protein kinase activation
Domoic acid (DA) is an excitatory amino acid analogue of kainic acid (KA) that acts via activation of glutamate receptors to elicit a rapid and potent excitotoxic response, resulting in neuronal cell death. Recently, DA was shown to elicit reactive oxygen species (ROS) production and induce apoptosis accompanied by activation of p38 mitogen-activated protein kinase (MAPK) in vitro. We have reported that WDR35, a WD-repeat protein, may mediate apoptosis in several animal models. In the present study, we administered DA to rats intraperitoneally, then used liquid chromatography/ion trap tandem mass spectrometry (LC-MS/MS) to identify and quantify DA in the brains of the rats and performed histological examinations of the hippocampus. We further investigated the potential involvement of glutamate receptors, ROS, p38 MAPK, and WDR35 in DA-induced toxicity in vivo.
- Open Access
- 10 December 2012
- Published by Springer Nature in BMC Neuroscience
- Vol. 13 (1) , 149
Bupivacaine-induced apoptosis independently of WDR35 expression in mouse neuroblastoma Neuro2a cells
Background: Bupivacaine-induced neurotoxicity has been shown to occur through apoptosis. Recently, bupivacaine was shown to elicit reactive oxygen species (ROS) production and induce apoptosis accompanied by activation of p38 mitogen-activated protein kinase (MAPK) in a human neuroblastoma cell line. We have reported that WDR35, a WD40-repeat protein, may mediate apoptosis through caspase-3 activation. The present study was undertaken to test whether bupivacaine induces apoptosis in mouse neuroblastoma Neuro2a cells and to determine whether ROS, p38 MAPK, and WDR35 are involved.Results: Our results showed that bupivacaine induced ROS generation and p38 MAPK activation in Neuro2a cells, resulting in apoptosis. Bupivacaine also increased WDR35 expression in a dose- and time-dependent manner. Hydrogen peroxide (H2O2) also increased WDR35 expression in Neuro2a cells. Antioxidant (EUK-8) and p38 MAPK inhibitor (SB202190) treatment attenuated the increase in caspase-3 activity, cell death and WDR35 expression induced by bupivacaine or H2O2. Although transfection of Neuro2a cells with WDR35 siRNA attenuated the bupivacaine- or H2O2-induced increase in expression of WDR35 mRNA and protein, in contrast to our previous studies, it did not inhibit the increase in caspase-3 activity in bupivacaine- or H2O2-treated cells.Conclusions: In summary, our results indicated that bupivacaine induced apoptosis in Neuro2a cells. Bupivacaine induced ROS generation and p38 MAPK activation, resulting in an increase in WDR35 expression, in these cells. However, the increase in WDR35 expression may not be essential for the bupivacaine-induced apoptosis in Neuro2a cells. These results may suggest the existence of another mechanism of bupivacaine-induced apoptosis independent from WDR35 expression in Neuro2a cells.
- 10 December 2012
- Published by Springer Nature in BMC Neuroscience
- Vol. 13 (1) , 149
Open AccessBupivacaine-induced apoptosis independently of WDR35 expression in mouse neuroblastoma Neuro2a cells
Background: Bupivacaine-induced neurotoxicity has been shown to occur through apoptosis. Recently, bupivacaine was shown to elicit reactive oxygen species (ROS) production and induce apoptosis accompanied by activation of p38 mitogen-activated protein kinase (MAPK) in a human neuroblastoma cell line. We have reported that WDR35, a WD40-repeat protein, may mediate apoptosis through caspase-3 activation. The present study was undertaken to test whether bupivacaine induces apoptosis in mouse neuroblastoma Neuro2a cells and to determine whether ROS, p38 MAPK, and WDR35 are involved.Results: Our results showed that bupivacaine induced ROS generation and p38 MAPK activation in Neuro2a cells, resulting in apoptosis. Bupivacaine also increased WDR35 expression in a dose- and time-dependent manner. Hydrogen peroxide (H2O2) also increased WDR35 expression in Neuro2a cells. Antioxidant (EUK-8) and p38 MAPK inhibitor (SB202190) treatment attenuated the increase in caspase-3 activity, cell death and WDR35 expression induced by bupivacaine or H2O2. Although transfection of Neuro2a cells with WDR35 siRNA attenuated the bupivacaine- or H2O2-induced increase in expression of WDR35 mRNA and protein, in contrast to our previous studies, it did not inhibit the increase in caspase-3 activity in bupivacaine- or H2O2-treated cells.Conclusions: In summary, our results indicated that bupivacaine induced apoptosis in Neuro2a cells. Bupivacaine induced ROS generation and p38 MAPK activation, resulting in an increase in WDR35 expression, in these cells. However, the increase in WDR35 expression may not be essential for the bupivacaine-induced apoptosis in Neuro2a cells. These results may suggest the existence of another mechanism of bupivacaine-induced apoptosis independent from WDR35 expression in Neuro2a cells.